Clinical Trial Update: Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on cicletanine in hypertension with diabetes discusses added magnesium to preserve potassium and sodium, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Hypertension
• Diabetes
• Hypokalemia
• Hyponatremia

Drugs mentioned

• Cicletanine (cicletanine)

Snippet

Sponsor: Navitas Pharma | Conditions: Arterial Hypertension, Diabetes | Phase 1, Phase 2 | Status: UNKNOWN